БАЛДАРДЫН СТЕРОИДГЕ МУКТАЖ НЕФРОТИКАЛЫК СИНДРОМУН ЦИТОТОКСИКАЛЫК ДАРЫЛООСУ
Жылдыз Аман кызы, Н.А. Бейшебаева, М.В. Кирсанова et al. · Evrazijskij žurnal zdravoohraneniâ. · 2024
Cytotoxic therapy by Cellcept was shown at 15 children with relapse, steroid depend nephrotic syndrome (NoS). Full remission of NoS is 60% of patients and duration till 1 year with cytotoxic therapy at 90 % and till 2 years without cytotoxic therapy at 10 %. Relapses are noted at 26 % of patients during cytotoxic therapy.
Cited by 0 works.